Connor Clark & Lunn Investment Management Ltd. raised its holdings in Relx Plc (NYSE:RELX - Free Report) by 103.4% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 444,360 shares of the technology company's stock after acquiring an additional 225,947 shares during the quarter. Connor Clark & Lunn Investment Management Ltd.'s holdings in Relx were worth $22,400,000 at the end of the most recent quarter.
A number of other institutional investors have also recently added to or reduced their stakes in RELX. Bleakley Financial Group LLC raised its position in shares of Relx by 1.5% in the first quarter. Bleakley Financial Group LLC now owns 14,147 shares of the technology company's stock valued at $713,000 after purchasing an additional 207 shares during the period. Cynosure Group LLC raised its position in shares of Relx by 3.5% in the first quarter. Cynosure Group LLC now owns 6,951 shares of the technology company's stock valued at $350,000 after purchasing an additional 236 shares during the period. Bridgewater Advisors Inc. raised its position in shares of Relx by 2.1% in the first quarter. Bridgewater Advisors Inc. now owns 11,463 shares of the technology company's stock valued at $617,000 after purchasing an additional 238 shares during the period. DRW Securities LLC raised its position in shares of Relx by 5.9% in the fourth quarter. DRW Securities LLC now owns 4,652 shares of the technology company's stock valued at $211,000 after purchasing an additional 259 shares during the period. Finally, Kovitz Investment Group Partners LLC increased its position in Relx by 3.4% during the fourth quarter. Kovitz Investment Group Partners LLC now owns 8,159 shares of the technology company's stock worth $371,000 after acquiring an additional 267 shares during the period. 15.02% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of equities analysts recently issued reports on RELX shares. Wall Street Zen raised shares of Relx from a "hold" rating to a "buy" rating in a research report on Saturday, July 26th. Morgan Stanley reaffirmed an "overweight" rating on shares of Relx in a research report on Wednesday, April 16th. Five equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Buy".
View Our Latest Report on Relx
Relx Trading Down 2.7%
Shares of Relx stock opened at $48.00 on Friday. The firm has a market capitalization of $88.16 billion, a PE ratio of 25.81, a price-to-earnings-growth ratio of 3.13 and a beta of 0.88. The company has a debt-to-equity ratio of 2.55, a current ratio of 0.47 and a quick ratio of 0.42. The company's fifty day moving average price is $52.80 and its two-hundred day moving average price is $51.60. Relx Plc has a 52-week low of $44.19 and a 52-week high of $56.33.
Relx Cuts Dividend
The firm also recently declared a semi-annual dividend, which will be paid on Tuesday, September 16th. Shareholders of record on Friday, August 8th will be issued a $0.2634 dividend. This represents a yield of 170.0%. The ex-dividend date of this dividend is Friday, August 8th. Relx's payout ratio is 27.96%.
Relx Company Profile
(
Free Report)
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Relx, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Relx wasn't on the list.
While Relx currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access Sale